Sodium valproate is a broad-spectrum anticonvulsant drug that has been on the UK market since 1973[1]. In UK, it licensed for treatment of epilepsy and bipolar disorder can also be considered in patients with episodic or chronic migraine[2]. Commonly used brands include Dyzantil (Aspire Pharma), Epilim (Sanofi), Episenta […]